Research Article| Volume 24, ISSUE 4, P281-288, July 2006

Dermatologic manifestations of parathyroid-related disorders


      Dermatologic manifestations of parathyroid-related disorders, although rare in sporadic cases, are not uncommon in familial syndromes.
      Patients with familial hyperparathyroidism have several types of skin lesions. In multiple endocrine neoplasia 1, patients commonly have angiofibromas (85%) and collagenomas (70%), lesions that show loss of one 11q13 allele, the molecular abnormality in multiple endocrine neoplasia 1. They can also present with lipomas or café-au-lait spots. Cutaneous amyloidosis, an entity that can occur sporadically, has been described in multiple endocrine neoplasia 2a and is usually localized to the interscapular area. Metastatic calcification is an entity commonly encountered in patients with hyperparathyroidism and renal failure. It can be complicated by infections and necrosis. It is best treated by controlling hypercalcemia, hyperphosphatemia, hyperparathyroidism, antibiotics, and analgesia. Parathyroidectomy is reserved for refractory cases.
      Hypoparathyroidism presenting in the context of polyglandular failure type 1 is characterized by mucocutaneous candidiasis. Pseudohypoparathyroidism, an inherited disorder with end-organ unresponsiveness to parathyroid hormone, is characterized by Albright hereditary osteodystrophy. Patients present with short stature, round facies, brachydactyly, and short fourth or fifth metacarpals.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinics in Dermatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. El-Hajj Fuleihan G. Parathyroid hormone secretion and action. In UpToDate CD ROM 14.1.

        • Diaz R.
        • El-Hajj Fuleihan G.
        • Brown E.M.
        Regulation of parathyroid function.
        in: Fray G.C.S. Handbook of Physiology, section 7: Endocrinology, volume III: Hormonal regulation water and electrolyte balance. Oxford University Press, New York1999
        • Kronenberg H.M.
        • Bringhurst R.F.
        • Segre G.V.
        • Potts Jr, J.T.
        Parathyroid hormone biosynthesis and metabolism.
        in: Bilezikian J.P. Marcus R. Levine M.A. The parathyroids: basic and clinical concepts. Academic Press, New York2001: 17-30
        • Brown E.M.
        • Pollak M.
        • Seidman C.E.
        • et al.
        Calcium-ion sensing cell surface receptors.
        N Engl J Med. 1995; 333: 234-240
        • Bilezikian J.P.
        • Brandi M.L.
        • Rubin M.
        • Silverberg S.J.
        Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features.
        J Int Med. 2005; 257: 6-17
      2. El-Hajj Fuleihan G. Clinical manifestations of hyperparathyroidism. In UpToDate CD ROM 14.1.

        • El-Hajj Fuleihan G.
        • Brown E.M.
        • Heath III, H.
        The familial benign hypocalciuric hypercalcemic syndromes.
        in: Bilezikian J.P. Raisz L.G. Rodan G.A. Principles of bone biology. Academic Press, San Diego (Calif)2002: 1031-1046
        • Marx S.J.
        • Stratakis C.A.
        Multiple endocrine neoplasia—Introduction.
        J Int Med. 2005; 257: 2-5
      3. Andrew A. Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2. In UpToDate CD ROM 14.1.

        • Leonhardt J.M.
        • Heymann W.R.
        Cutaneous manifestations of other endocrine diseases.
        in: Freedberg I.M. Eisen A.Z. Wolff K. Fitzpatrick's dermatology in general medicine. 6th ed. McGraw-Hill, New York2003: 1662-1670
        • Dagher H.N.
        • Aboujaoude Z.C.
        • Jabbour S.A.
        Chronic urticaria: an unusual manifestation of primary hyperparathyroidism.
        Endocr Pract. 2002; 8: 47-49
        • Argawal S.K.
        • Burns A.L.
        • Sukhodolets K.E.
        • et al.
        Molecular pathology of the MEN1 gene.
        Ann NY Acad Sci. 2004; 1014: 189-198
        • Pack S.
        • Turner M.L.
        • Zhuang Z.
        • et al.
        Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the Men1 gene.
        J Invest Dermatol. 1998; 11: 438-440
        • Ceccherini I.
        • Romei C.
        • Barone V.
        • et al.
        Identification of the Cys634→Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous amyloidosis.
        J Endocrinol Invest. 1994; 17: 201-204
        • Verga U.
        • Fugazzola L.
        • Cambiaghi S.
        • et al.
        Frequent association between MEN 2A and cutaneous lichen amyloidosis.
        Clin Endocrinol. 2003; 59: 156-161
        • Walsh J.S.
        • Fairley J.A.
        Cutaneous mineralization and ossification.
        in: Freedberg I.M. Eisen A.Z. Wolff K. Fitzpatrick's dermatology in general medicine. 6th ed. McGraw-Hill, New York2003: 1490-1496
        • Selye H.
        Calciphylaxis. University of Chicago Press, Chicago (Ill)1962: 1-100
        • Hafner J.
        • Keusch G.
        • Wahl C.
        • et al.
        Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic renal failure and benefit from parathyroidectomy.
        J Am Acad Dermatol. 1995; 33: 954-962
        • Angelis M.
        • Wong L.L.
        • Myers S.A.
        • et al.
        Caciphylaxis in patients on hemodialysis: a prevalence study.
        Surgery. 1997; 122: 1083-1090
        • Zouboulis C.C.
        • Blume-peytavi U.
        • Lennert T.
        • et al.
        Fulminant metastatic calcinosis with cutaneous necrosis in a child with end-stage renal disease and tertiary hyperparathyroidism.
        Br J Dermatol. 1996; 135: 617-622
        • Mirza I.
        • Chaubay D.
        • Gunderia H.
        • et al.
        An unusual presentation of calciphylaxis due to primary hyperparathyroidism.
        Arch Pathol Lab Med. 2001; 125: 1351-1353
        • Oh D.H.
        • Eulau D.
        • Tokugawa D.A.
        • et al.
        Five cases of calciphylaxis and a review of the literature.
        J Am Acad Dermatol. 1999; 40: 979-987
        • Hafner J.
        • Keusch G.
        • Wahl C.
        • Burg G.
        Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure.
        Vasa. 1998; 27: 137-143
        • Fischer A.H.
        • Morris D.J.
        Pathogenesis of calciphylaxis: study of three cases with literature review.
        Hum Pathol. 1995; 26: 1055-1064
        • Bilezikian J.P.
        • Potts Jr, J.T.
        • El-HajjFuleihan G.
        • et al.
        Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.
        J Clin Endocrinol Metab. 2002; 87: 5353-5361
        • Sharma V.K.
        • Khandpur S.
        • Khanna N.
        An interesting case of unilateral angiofibromas successfully treated with pulsed dye laser.
        J Eur Acad Dermatol Venereol. 2004; 18: 641-642
        • Tope W.D.
        • Kageyama N.
        “Hot” KTP-laser treatment of facial angiofibromata.
        Lasers Surg Med. 2001; 29: 78-81
        • Bittencourt R.C.
        • Huilgol S.C.
        • Seed P.T.
        • et al.
        Treatment of angiofibromas with a scanning carbon dioxide laser: a clinicopathologic study with long-term follow up.
        J Am Acad Dermatol. 2001; 45: 731-735
        • Chou F.F.
        • Ho J.C.
        • Huang S.C.
        • Scheen-Chen S.M.
        A study on pruritus after parathyroidectomy for secondary hyperparathyroidism.
        J Am Coll Surg. 2000; 190: 65-70
        • Stahle-Backdahl M.
        • Hagermark O.
        • Lins L.E.
        • et al.
        Experimental and immunohistochemical studies on the possible role of parathyroid hormone in uremic pruritus.
        J Int Med. 1989; 225: 411-415
        • Podymow T.
        • Wherrett C.
        • Burns K.D.
        Hyperbaric oxygen in the treatment of calciphylaxis: a case series.
        Nephrol Dial Transplant. 2001; 16: 2176-2180
        • Cicone J.S.
        • Petronis J.B.
        • Embert C.D.
        • et al.
        Successful treatment of calciphylaxis with intravenous sodium thiosulfate.
        Am J Kidney Dis. 2004; 43: 1104-1108
        • Brucculeri M.
        • Cheigh J.
        • Bauer G.
        • et al.
        Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis.
        Semin Dial. 2005; 18: 431-434
        • Jabbour S.A.
        Cutaneous manifestations of endocrine disorders: a guide for dermatologists.
        Am J Clin Dermatol. 2003; 4: 315-331
      4. Agus Z. Etiology of hypocalcemia in adults. In UpToDate CD ROM 14.1.

        • Akinsoto O.P.A.
        • Jabbour S.A.
        Polyglandular autoimmune syndrome, type1.
        • Eddy M.C.
        • Jean De Beur S.M.
        • Yandow S.M.
        • et al.
        Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification.
        J Bone Miner Res. 2000; 15: 2074-2083
        • Paller A.
        Primary immunodeficiencies.
        in: Freedberg I.M. Eisen A.Z. Wolff K. Fitzpatrick's dermatology in general medicine. 6th ed. McGraw-Hill, New York2003: 835-852
        • Aslan Y.
        • Gedik Y.
        • Okten A.
        • et al.
        Congenital primary hypoparathyroidism presented with extensive cutaneous and sub-cutaneous calcifications.
        Turk J Pediatr. 1999; 41: 253-257
        • Gueydan M.
        • Folchetti G.
        • Christofilis M.A.
        • et al.
        Impetigo herpetiformis, a rare manifestation of severe hypocalcemia.
        Ann Endocrinol (Paris). 2002; 63: 502-504
        • Lee Y.
        • Nam Y.-H.
        • Lee J.-H.
        • et al.
        Hypocalcemia-induced pustular psoriasis–like skin eruption.
        Br J Dermatol. 2005; 152: 591-593
        • Aksoylar S.
        • Aydinok Y.
        • Serdaroglu E.
        • et al.
        HDR (hypoparathyroidism, sensorineural deafness, renal dysplasia) syndrome presenting with hypocalcemia-induced generalized psoriasis.
        J Pediatr Endocrinol Metab. 2004; 17: 1031-1034
        • Kirkpatrick C.H.
        Chronic mucocutaneous candidiasis.
        J Am Acad Dermatol. 1994; 31: S14-S17